Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mesothelioma × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 39 Prostatic Neoplasms 38 Multiple Myeloma 17 Neoplasm Metastasis 14 Osteoporosis 12 Pain 9 Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 4 Fractures, Bone 4 Neoplasms, Plasma Cell 3 Lymphoma 3 Carcinoma, Renal Cell 3 Bone Diseases, Metabolic 3 Bone Diseases 3 Spinal Cord Compression 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Kidney Neoplasms 2 Humoral Hypercalcemia Of Malignancy 2 Treatment of Bone Metastases 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Pleural Effusion, Malignant 1 Paraproteinemias 1 Osteonecrosis 1 Osteolysis 1

Interventions

Pemetrexed 20 Cisplatin 16 Nivolumab 8 Gemcitabine 7 Ipilimumab 6 Carboplatin 6 tazemetostat 3 pembrolizumab 3 durvalumab 3 Fluorouracil 3 Bevacizumab 3 niraparib 2 budigalimab 2 belinostat 2 anetumab ravtansine 2 Vinorelbine 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 PM 01183 2 Oxaliplatin 2 Imatinib Mesylate 2 Everolimus 2 Erlotinib Hydrochloride 2 Doxorubicin 2 venetoclax 1 tremelimumab 1 trametinib 1 spartalizumab 1 sodium thiosulfate 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡